# Dogwood Therapeutics, Inc.: Form 8-K, filed May 20, 2024

- Company: [Dogwood Therapeutics, Inc.](/companies/dwtx.md) (CIK 1818844)
- Form: 8-K
- Filed: 2024-05-20
- Accepted by EDGAR: May 20, 2024, 09:28 ET
- Period: 2024-05-19
- Accession: 0001558370-24-008450
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/viri-20240519x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/viri-20240519x8k.htm

Filed May 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-008450. Last ingested by Listed: Nov 5, 2026, 12:28 ET. No prices; not investment advice.